Drug Discovery

#Artificial intelligence (AI) #Data automation #Drug discovery #Laboratory data #Webinar

Register now and save up to eight hours weekly on data management

The adoption of AI/ML in life science R&D is hindered by the lack of high-quality, well-structured data and metadata, a challenge exacerbated by a proliferation of proprietary instrument data formats, siloed lab software applications, and the absence of wet lab-friendly data automation platforms. While some workflow-specific solutions exist, they are… Read More

Webinar date:
Supported by Benchling
#News

#Drug discovery

eBook: Unifying Data Sources: A Guide for Efficient, Comprehensive Research

In “Three Ways to Solve Scientific FOMO: Advice for Navigating Early Discovery,” we explore key functions that empower researchers to overcome the challenges of siloed data, including: Leveraging ontologies  Utilising search alerts  Effectively employing AI Read our ebook to learn how you can accelerate your breakthroughs in drug discovery. … Read More

#eBooks

Synthetic DNA
#Drug discovery #Protein chemistry / Proteomics #Protein engineering #Synthetic biology #Synthetic DNA #Webinar

Webinar: Successfully express high-quality synthetic DNA in TXTL systems

A new webinar is now open for registration entitled ‘Using ENFINIA cell-free synthesised DNA for rapid protein expression and screening in the myTXTL cell-free system‘. Cell-free transcription-translation (TXTL) systems can be used for rapid and flexible protein expression and screening workflows, powering protein engineering and discovery, synthetic biology, AI-driven… Read More

Webinar date:
Supported by Elegen Bio
#News

#2025 predictions #Drug development #Drug discovery #Regulatory

Regulation and drug policy: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Previously, with a focus on technology, machine learning (ML) and artificial intelligence (AI), as well as neuroscience, cancer research, cell and gene therapy and diagnostics. Here, looking at regulation and drug policy.  Ariel… Read More

#Exclusive Content #Regulatory #Trends & Analysis

#Drug discovery

App Note: Unlock the Power of Multiplexing for High-Throughput Single-Cell Analysis and Isolation

Discover Cyto-Mine® Chroma and picodroplet technology for advanced single-cell analysis: Multiplexing: Simultaneously detect and isolate rare secreting cells using secreted and cellular markers. Ultra-High-Throughput: Efficiently process and sort millions of cells with high accuracy. Cell viability: Maintain high viability and accuracy using complex assays. Download the application note to transform… Read More

#App Notes

#Cell line development #Cell lines #Drug discovery #Interview #Tune Therapeutics

Innovating biopharmaceuticals: The benefits of cell line development

DDW’s Megan Thomas speaks to Dr Lucas Thompson, Senior Director of Research at Tune Therapeutics, about the advancements in cell line development and how biotechnologies can enhance the precision and efficiency of therapeutic protein production. MT: What are the benefits cell line development is bringing to biopharmaceutical developers? LT: For… Read More

#Exclusive Content

Gene sequence
#Drug discovery #High throughput screening #Lab technology #Next generation sequencing #Roche

Will Roche’s new SBX technology revolutionise sequencing?

Roche has unveiled its new breakthrough sequencing by expansion (SBX) technology, establishing a new category of next-generation sequencing.   According to the company, SBX chemistry, combined with an innovative sensor module, offers ultra-rapid, high-throughput sequencing that is both flexible and scalable for a broad range of applications. … Read More

#News #Trending News

#Drug development #Drug discovery #Interview #NanoTemper Technologies #Sitting Down With #Vodcast

New vodcast: Sitting Down With… Philipp Baaske, NanoTemper

DDW’s Megan Thomas caught up with Philipp Baaske, Co-Founder & Executive Chairman of NanoTemper Technologies, about biophysical characterisation techniques for complex biologics. Highlights of the Vodcast As drug discovery moves beyond traditional small molecules, biophysical characterisation techniques must evolve to keep pace with the increasing complexity of new drug… Read More

#News

#Artificial intelligence (AI) #Data automation #Drug discovery #Laboratory data #Webinar

Webinar: Enable AI-ready data with data automation

The adoption of AI/ML in life science R&D is hindered by the lack of high-quality, well-structured data and metadata, a challenge exacerbated by a proliferation of proprietary instrument data formats, siloed lab software applications, and the absence of wet lab-friendly data automation platforms. While some workflow-specific solutions exist, they are… Read More

Webinar date:
Supported by Benchling
#News

Synthetic DNA
#Drug discovery #Protein chemistry / Proteomics #Protein engineering #Synthetic biology #Synthetic DNA #Webinar

Webinar: Ensure rapid, efficient and streamlined in vitro workflows

A new webinar is now open for registration entitled ‘Using ENFINIA cell-free synthesised DNA for rapid protein expression and screening in the myTXTL cell-free system‘. Cell-free transcription-translation (TXTL) systems can be used for rapid and flexible protein expression and screening workflows, powering protein engineering and discovery, synthetic biology, AI-driven… Read More

Webinar date:
Supported by Elegen Bio
#News

#2025 predictions #Diagnostics #Drug discovery

Diagnostics: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Previously, with a focus on technology, machine learning (ML) and artificial intelligence (AI), as well as neuroscience, cancer research and cell and gene therapy. Here, looking through a diagnostics lens.  Jackie… Read More

#Business & Investment #Exclusive Content #Trends & Analysis